BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37876983)

  • 1. Leptin Mediates Prostate Stromal Cell Proliferation, Smooth Muscle Contraction, and Mitochondrial Function in Benign Prostate Hyperplasia.
    Wang X; Guo L; Liu G; Liu T
    Diabetes Metab Syndr Obes; 2023; 16():3261-3273. PubMed ID: 37876983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ghrelin Aggravates Prostate Enlargement in Rats with Testosterone-Induced Benign Prostatic Hyperplasia, Stromal Cell Proliferation, and Smooth Muscle Contraction in Human Prostate Tissues.
    Wang X; Wang Y; Gratzke C; Sterr C; Yu Q; Li B; Strittmatter F; Herlemann A; Tamalunas A; Rutz B; Ciotkowska A; Waidelich R; Liu C; Stief CG; Hennenberg M
    Oxid Med Cell Longev; 2019; 2019():4748312. PubMed ID: 31885795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: A novel remedy in LUTS?
    Tamalunas A; Sauckel C; Ciotkowska A; Rutz B; Wang R; Huang R; Li B; Stief CG; Gratzke C; Hennenberg M
    Prostate; 2021 May; 81(7):377-389. PubMed ID: 33687083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α
    Wang X; Li B; Ciotkowska A; Rutz B; Erlander MG; Ridinger M; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Eur J Pharmacol; 2020 Apr; 873():172985. PubMed ID: 32017934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lenalidomide and pomalidomide inhibit growth of prostate stromal cells and human prostate smooth muscle contraction.
    Tamalunas A; Sauckel C; Ciotkowska A; Rutz B; Wang R; Huang R; Li B; Stief CG; Gratzke C; Hennenberg M
    Life Sci; 2021 Sep; 281():119771. PubMed ID: 34186051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003.
    Liu Y; Wang R; Huang R; Rutz B; Ciotkowska A; Tamalunas A; Hu S; Trieb M; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Front Pharmacol; 2023; 14():1105427. PubMed ID: 37188272
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864.
    Wang Y; Kunit T; Ciotkowska A; Rutz B; Schreiber A; Strittmatter F; Waidelich R; Liu C; Stief CG; Gratzke C; Hennenberg M
    Br J Pharmacol; 2015 Jun; 172(11):2905-17. PubMed ID: 25631101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent alpha
    Huang R; Liu Y; Ciotkowska A; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Front Pharmacol; 2021; 12():666047. PubMed ID: 34248624
    [No Abstract]   [Full Text] [Related]  

  • 9. A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate.
    Yu Q; Gratzke C; Wang R; Li B; Kuppermann P; Herlemann A; Tamalunas A; Wang Y; Rutz B; Ciotkowska A; Wang X; Strittmatter F; Waidelich R; Stief CG; Hennenberg M
    J Biol Chem; 2019 Aug; 294(32):12231-12249. PubMed ID: 31243101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate.
    Wang Y; Gratzke C; Tamalunas A; Wiemer N; Ciotkowska A; Rutz B; Waidelich R; Strittmatter F; Liu C; Stief CG; Hennenberg M
    PLoS One; 2016; 11(4):e0153312. PubMed ID: 27071060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule Gα
    Tamalunas A; Wendt A; Springer F; Ciotkowska A; Rutz B; Wang R; Huang R; Liu Y; Schulz H; Ledderose S; Magistro G; Stief CG; Hennenberg M
    Front Physiol; 2022; 13():884057. PubMed ID: 35677088
    [No Abstract]   [Full Text] [Related]  

  • 12. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
    Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
    Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of α
    Huang R; Liu Y; Hu S; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of CDC42 inhibits contraction and growth-related functions in prostate stromal cells, which is mimicked by ML141.
    Wang R; Huang R; Liu Y; Tamalunas A; Stief CG; Hennenberg M
    Life Sci; 2023 Sep; 329():121928. PubMed ID: 37437651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADP Ribosylation Factor 6 Promotes Contraction and Proliferation, Suppresses Apoptosis and Is Specifically Inhibited by NAV2729 in Prostate Stromal Cells.
    Wang R; Schneider S; Keppler OT; Li B; Rutz B; Ciotkowska A; Stief CG; Hennenberg M
    Mol Pharmacol; 2021 Oct; 100(4):356-371. PubMed ID: 34349027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusor.
    Li B; Wang X; Rutz B; Wang R; Tamalunas A; Strittmatter F; Waidelich R; Stief CG; Hennenberg M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):829-842. PubMed ID: 31867686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic intervention.
    Yu Q; Gratzke C; Wang Y; Wang X; Li B; Strittmatter F; Herlemann A; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Prostate; 2019 May; 79(7):746-756. PubMed ID: 30811062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983.
    Huang R; Liu Y; Li B; Wang R; Tamalunas A; Waidelich R; Strittmatter F; Stief CG; Hennenberg M
    Prostate; 2022 Jan; 82(1):59-77. PubMed ID: 34633103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permixon®, hexane-extracted Serenoa repens, inhibits human prostate and bladder smooth muscle contraction and exerts growth-related functions in human prostate stromal cells.
    Tamalunas A; Wendt A; Springer F; Vigodski V; Ciotkowska A; Rutz B; Wang R; Huang R; Liu Y; Schulz H; Ledderose S; Kolben T; Magistro G; Stief CG; Hennenberg M
    Life Sci; 2022 Nov; 308():120931. PubMed ID: 36084760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.